Mitsubishi UFJ Asset Management »

Cerevel Therapeutics Hldng I shares owned by Mitsubishi UFJ Asset Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Mitsubishi UFJ Asset Management from 13F filings

Historical chart of Mitsubishi UFJ Asset Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Mitsubishi UFJ Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Mitsubishi UFJ Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.9k 211 42.09
2023-09-30 $4.6k 211 21.83

More positions owned by Mitsubishi UFJ Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Visa Com Cl A (V)
NVIDIA Corporation (NVDA)
Philip Morris International (PM)
Accenture Plc Ireland Shs Class A (ACN)
Thermo Fisher Scientific (TMO)
Procter & Gamble Company (PG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Danaher Corporation (DHR)
Abbott Laboratories (ABT)
Intercontinental Exchange (ICE)

View all positions for Mitsubishi UFJ Asset Management

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I